Loading...

PRGO PERRIGO CO PLC Disposals and divestitures 8-K Filing

PRRG

PRG

PERRIGO CO PLC

(PRGO)

2026 8-K

Earnings Report

Annual Meeting Results

Transaction Closure

New Reporting Structure

Credit Agreement Update

Earnings Report

Earnings Announcement

Financial Statements

Asset Acquisitions

Financial Statements

Earnings Announcement

CEO Agreement Extended

Board Member Retirement

Board Appointment

Insurance Settlement

Earnings Correction

Earnings Release

Earnings Report

Recall of Infant Formula

Earnings Report

Resignation of Director

Sale of Rare Diseases Busin...

Appointment of Director

Management Changes

Earnings Release

Management Changes

Sale of HRA Pharma Rare Dis...

Departure of Directors

Earnings Release

Incremental Amendment to Cr...

Tender Offer Results

Earnings Release

Departure and Appointment

Appointment of Director

Earnings Release

Appointment of CEO

Annual General Meeting of S...

Management Change

Earnings Release

IRS Letter on Athena Neuros...

Earnings Release

Departure of Directors

External Links:

Perrigo Co plc completed the sale of its Dermacosmetics Business on April 30, 2026, receiving €305.6 million from Karo Healthcare AB, with potential for an additional €27 million based on future performance.

AI Assistant

PERRIGO CO PLC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.